International Clinical Trial: Can metformin reduce heart muscle thickening and improve exercise capacity in people with heart failure with preserved ejection fraction who are overweight or have insulin resistance?

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ISRCTN74144960) titled 'Can metformin reduce heart muscle thickening and improve exercise capacity in people with heart failure with preserved ejection fraction who are overweight or have insulin resistance?' on July 26.

Study Type: Interventional

Study Design: Allocation: Randomized controlled trial Masking: Blinded (masking used) Control: Placebo Assignment: Parallel Purpose: Treatment

Primary Sponsor: University of Sulaimani

Condition: Heart failure with preserved ejection fraction (HFpEF), New York Heart Association (NYHA) Class II-III, insulin resistance, pre-diabetes, obesity Circulatory System

Intervention: Eligible particip...